» Articles » PMID: 37656980

Determinants of Cervical Cancer Screening Among Women Aged 30-49 Years Old in Four African Countries: A Cross-Sectional Secondary Data Analysis

Overview
Journal Cancer Control
Specialty Oncology
Date 2023 Sep 1
PMID 37656980
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Early-stage cervical cancer screening is essential for providing women with a better chance of receiving effective treatment for precancerous and cancer stages. Delay in cervical cancer screening results in late presentation and cancer metastasis. National-level cervical cancer screening in resource-limited countries was scarce and not well studied in Africa based on national data specifically in Kenya, Cameroon, Nambia, and Zimbabwe.

Objective: To determine the prevalence and determinants of cervical cancer screening among eligible women in Kenya, Cameroon, Nambia, and Zimbabwe.

Methods: This study analyzed demographic and health survey data from Kenya, Cameroon, Nambia, and Zimbabwe. The data were extracted and analyzed by STATA version 15 and further analysis was done. Intraclass correlation coefficient, median odds ratio, and proportional change in variance were calculated to check the appropriateness of multilevel analysis. Variables with -value < .25 were selected for multivariable multilevel logistic regression analysis. Finally, statistical significance between dependent and independent variables was assessed by odds ratios and 95% confidence intervals.

Results: The prevalence of cervical cancer screening in 4 African countries (Nambia, Kenya, Cameroon, and Zimbabwe) was 23.4 [95%CI: 22.8-24.1]. The determinants identified in this study were women of age 41-50 years [AOR = 1.47; 95% CI 1.24, 1.73], rural residence [AOR = .67; 95% CI .55, .81], women who have their own work [AOR = 1.1; 95% CI 1.0, 1.37], smoking status [AOR = 1.89; 95% CI 1.17, 3.0], age at first birth >=35 [AOR = 5.27; 95% CI 1.29-21.52], condom use [AOR = 1.79; 95% CI 1.46,2.19], husbands having worked [AOR = 1.5; 95% CI 1.08,2.11], rich household wealth [AOR = 1.43; 95% CI 1.13,1.8], and having health insurance [AOR = 2.2; 95% CI 1.8,2.7].

Conclusion: The prevalence of cervical cancer screening in Kenya, Cameroon, Nambia, and Zimbabwe was low as compared to World Health Organization (WHO) recommendations. Age, residence, work status, smoking status, women's age at first birth, condom use, husbands having work, wealth status, and health insurance were the identified determinants of cervical cancer screening. Programme and policy interventions could address younger, rural residence women, poor wealth status women, women without work, and those who never use health insurance for the uptake of cervical cancer screening.

Citing Articles

Long-acting reversible and permanent contraceptives utilization and its associated factors among married women who desire no more children in Ethiopia: A multilevel analysis.

Tsega N, Biset W, Aragaw G, Abiy S, Godana T, Dagnaw A PLoS One. 2025; 20(1):e0316799.

PMID: 39854289 PMC: 11760555. DOI: 10.1371/journal.pone.0316799.


Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.

Xavier S, da Silva K, Galvao N, das Neves M, de Queiroz Neves Almeida A, Silva A World J Surg Oncol. 2024; 22(1):269.

PMID: 39385163 PMC: 11463162. DOI: 10.1186/s12957-024-03518-y.


Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.

Anaba E, Alor S, Badzi C, Mbuwir C, Muki B, Afaya A BMC Cancer. 2024; 24(1):920.

PMID: 39080553 PMC: 11290011. DOI: 10.1186/s12885-024-12697-6.

References
1.
Marashi T, Irandoost S, Yoosefi Lebni J, Soofizad G . Exploring the barriers to Pap smear test in Iranian women: a qualitative study. BMC Womens Health. 2021; 21(1):287. PMC: 8348840. DOI: 10.1186/s12905-021-01428-9. View

2.
Cowburn S, Carlson M, Lapidus J, DeVoe J . The association between insurance status and cervical cancer screening in community health centers: exploring the potential of electronic health records for population-level surveillance, 2008-2010. Prev Chronic Dis. 2013; 10:E173. PMC: 3809921. DOI: 10.5888/pcd10.130034. View

3.
Sugawara Y, Tsuji I, Mizoue T, Inoue M, Sawada N, Matsuo K . Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women. Jpn J Clin Oncol. 2018; 49(1):77-86. DOI: 10.1093/jjco/hyy158. View

4.
Ba D, Ssentongo P, Musa J, Agbese E, Diakite B, Traore C . Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study. Cancer Epidemiol. 2021; 72:101930. PMC: 8864323. DOI: 10.1016/j.canep.2021.101930. View

5.
. STROBE statement--checklist of items that should be included in reports of observational studies (STROBE initiative). Int J Public Health. 2008; 53(1):3-4. DOI: 10.1007/s00038-007-0239-9. View